A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection

NCT04076423 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

141

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Dual Therapy
DRUG: Triple therapy

Sponsor

Fundacion SEIMC-GESIDA